Log in

Start Your Membership Now

Researchers from the Veterans Affairs St. Louis Health Care System found that veterans with type 2 diabetes who were prescribed glucagon-like peptide-1 receptor agonists (GLP-1s) had a lower risk of developing substance use disorders (SUDs) compared to those prescribed sodium-glucose cotransporter-2 (SGLT-2) inhibitors, according to a study published in The BMJ.

The study was conducted to examine whether GLP-1 medications—originally developed to treat type 2 diabetes and increasingly used for weight management—are associated with differences in addiction risk and outcomes, given emerging evidence that these medications may influence reward and addictive . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.

Editor’s Picks

Latest Resources
See All
13.6 Million People Were Dual Eligibles For At Least One Month In 2022
There were 13.6 million people who were fully or partially dually eligible for Medicare and Medicaid for at least one month in 2022, according to a recent report conducted by two independent congressional agencies, the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission. Combined state and federal spending for dual eligibles totaled $548.8 billion in calendar year 2022. Medicare accounted for $351.4 billion (64%). About 38% of dual eligibles were… Read

To sign-up for monthly Chronic Disease Management alerts, you must be signed in to your account.

Government Contract Bidding Opportunities

Government Contract Award Announcements